Sski (potassium iodide) NDC 17856-0114

NDC codes

FDA NDC Directory

Product NDC (as listed)17856-0114Labeler and product segments. Claims need a package NDC.

Product NDC at billing width17856-0114Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
17856-0114-1	17856011401	120 SYRINGE in 1 BOX, UNIT-DOSE (17856-0114-1) / .1 mL in 1 SYRINGEMarketed from Aug 18, 2023
17856-0114-2	17856011402	120 SYRINGE in 1 BOX, UNIT-DOSE (17856-0114-2) / .1 mL in 1 SYRINGEMarketed from Aug 18, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sski
Generic name (nonproprietary): potassium iodide
Active ingredients: Potassium iodide — 1 g/mL
Dosage form: Solution
Route: Oral
Labeler: ATLANTIC BIOLOGICALS CORP.
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Nov 13, 2017
Listing expires: Dec 31, 2026
Identifiers: Product ID 17856-0114_36341581-eb16-560d-e063-6394a90afb4aSPL ID 36341581-eb16-560d-e063-6394a90afb4aSPL set ID 664e6cd9-6a3c-49ef-a7b2-d09f0338b549RxCUI 312541UNII 1C4QK22F9J

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N417856011401 followed by a unit qualifier and the quantity

Package 17856-0114-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 28, 2025.

Indications (excerpt from the label)

Indications and Usage SSKI ® (potassium iodide oral solution, USP) is for use as an expectorant in the symptomatic treatment of chronic pulmonary diseases where tenacious mucus complicates the problem, including bronchial asthma, bronchitis and pulmonary emphysema.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)